Overview

Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of adding liraglutide to high dose insulin therapy compared to high dose insulin therapy alone in patients with insulin-treated Type 2 diabetes with insulin requirements of > 100 units of insulin per day.
Phase:
Phase 4
Details
Lead Sponsor:
Mountain Diabetes and Endocrine Center
Treatments:
Insulin
Insulin, Globin Zinc
Liraglutide